Larry C. Renfro

LARRY C. RENFRO

Managing Partner at Optum Ventures

ActiveInvestor
Website
Updated: ·

About

Larry C. Renfro serves as Managing Partner at Optum Ventures, a leading venture capital firm focused on healthcare innovation. In this role, he spearheads strategic investments in companies transforming the healthcare landscape through digital health, data analytics, and advanced care delivery models. His leadership drives Optum Ventures' mission to foster groundbreaking solutions that improve health outcomes and experiences.

Experience

Deep Dive

Larry C. Renfro stands as a pivotal figure in healthcare innovation and venture capital, currently serving as the Managing Partner at Optum Ventures. In this influential role, Mr. Renfro guides the firm's strategic investment initiatives, focusing on identifying and nurturing companies that are poised to revolutionize the healthcare industry. Optum Ventures, under his leadership, targets early-stage and growth-stage companies developing cutting-edge solutions in areas such as digital health, data analytics, artificial intelligence, consumer engagement, and advanced care delivery. The firm's mission is deeply aligned with improving health outcomes, enhancing patient experiences, and driving efficiency across the healthcare ecosystem.

Mr. Renfro's extensive career background provides a robust foundation for his work at Optum Ventures. Prior to his current position, he held significant leadership roles within UnitedHealth Group, the parent company of Optum. Notably, he served as Vice Chairman of UnitedHealth Group and Chief Executive Officer of Optum, a diversified health services company. During his tenure as CEO of Optum, he was instrumental in expanding its capabilities across health services, technology, and data, transforming it into a multi-billion dollar enterprise that serves millions of people globally. His strategic vision helped integrate data, analytics, and technology to create more connected and efficient healthcare solutions.

His deep understanding of the complexities of the healthcare system, coupled with his proven track record in scaling large organizations, makes him a formidable leader in the venture capital space. At Optum Ventures, Larry C. Renfro leverages this expertise to identify promising startups that can bring innovative technologies and business models to market. While specific individual investments are typically attributed to the fund, Optum Ventures has a strong portfolio reflecting its focus on areas like virtual care platforms, precision medicine, behavioral health solutions, and healthcare payment innovation. Companies within their portfolio often aim to solve critical challenges such as access to care, cost reduction, and quality improvement.

Under Mr. Renfro's guidance, Optum Ventures not only provides capital but also offers strategic support, industry insights, and access to Optum's vast network and resources. This collaborative approach helps portfolio companies accelerate their growth and achieve their full potential, ultimately contributing to a more advanced and patient-centric healthcare future. His leadership ensures that Optum Ventures remains at the forefront of investing in the next generation of healthcare disruptors.

Frequently Asked Questions

Who is Larry C. Renfro?

Larry C. Renfro is the Managing Partner at Optum Ventures, a leading venture capital firm specializing in healthcare innovation. He is also a prominent figure with a distinguished career in healthcare leadership, including serving as Vice Chairman of UnitedHealth Group and CEO of Optum.

What does Larry C. Renfro invest in?

Larry C. Renfro, through Optum Ventures, invests in early-stage and growth-stage companies focused on transforming healthcare. Key investment areas include digital health, data analytics, artificial intelligence, consumer engagement, and advanced care delivery models.

Where does Larry C. Renfro work?

Larry C. Renfro works as the Managing Partner at Optum Ventures. Optum Ventures is a venture capital firm dedicated to investing in innovative healthcare companies.